triazoles has been researched along with Leukemia, Lymphoblastic, Acute, T Cell in 13 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (7.69) | 29.6817 |
| 2010's | 11 (84.62) | 24.3611 |
| 2020's | 1 (7.69) | 2.80 |
| Authors | Studies |
|---|---|
| Bandettini, R; Barco, S; Carrega, G; Castagnola, E; Dallorso, S; Dufour, C; Mesini, A; Miano, M; Palmisani, E; Saffioti, C | 1 |
| Aerts, S; Atak, ZK; Bornschein, S; Clappier, E; Cobos, FA; Cools, J; de Bock, CE; Decaesteker, B; Durinck, K; Soulier, J; Speleman, F; Taghon, T; Van Loocke, W; Van Vlierberghe, P; Vandesompele, J; Verboom, K; Volders, PJ | 1 |
| Labbadia, F; Sanchez-Salinas, A | 1 |
| Aster, JC; Bernstein, BE; Bradner, JE; Brehm, MA; Cotton, MJ; Fernandez, D; Gillespie, SM; Greiner, DL; Gutierrez, A; Jain, M; Kelliher, MA; Kluk, MJ; Knoechel, B; Ku, M; Kung, AL; Lohr, JG; Ott, CJ; Pearson, D; Piccioni, F; Roderick, JE; Root, DE; Shultz, LD; Silver, SJ; Stegmaier, K; Wang, H; Williamson, KE; Zhu, J | 1 |
| Castellano, R; Collette, Y; Crouzet, T; Gon, S; Goubard, A; Loosveld, M; Nadel, B; Payet-Bornet, D; Pouyet, L; Prebet, T; Vey, N | 1 |
| Ito, TK; Kadariya, Y; Pei, J; Sementino, E; Tan, Y; Testa, JR | 1 |
| Anderson, NM; Feng, H; Fu, H; Kelliher, MA; Landesman-Bollag, E; Li, D; Lian, H; Roderick, JE; Seldin, DC; Tang, KC; Zhang, G; Zhou, Y | 1 |
| Berx, G; Bornhauser, BC; Bourquin, JP; Dobay, MP; Frismantas, V; Goossens, S; Lintermans, B; Matthijssens, F; Peirs, S; Pieters, T; Poppe, B; Van Loocke, W; Van Vlierberghe, P; Vandamme, N | 1 |
| Alves, G; Bigni, R; de Andrade, CF; Pereira, DA; Pombo-de-Oliveira, MS | 1 |
| Barata, JT; Brandalise, SR; Jotta, PY; Ribeiro, D; Silva, A; Silveira, AB; Yunes, JA | 1 |
| Accoceberry, I; Gabriel, F; Noel, T | 1 |
| Belitsky, G; Budunova, I; Gordon, LI; Kirsanov, K; Lesovaya, E; Popa, A; Rosen, ST; Yakubovskaya, M; Yemelyanov, A | 1 |
13 other study(ies) available for triazoles and Leukemia, Lymphoblastic, Acute, T Cell
| Article | Year |
|---|---|
Intravenous isavuconazole can be administered 5 days-a-week. A possibility suggested by a real-life observation.
Topics: Administration, Intravenous; Antifungal Agents; Aspergillosis; Child; Drug Monitoring; Humans; Male; Nitriles; Precursor T-Cell Lymphoblastic Leukemia-Lymphoma; Pyridines; Triazoles | 2020 |
A comprehensive inventory of TLX1 controlled long non-coding RNAs in T-cell acute lymphoblastic leukemia through polyA+ and total RNA sequencing.
Topics: Azepines; Cell Line, Tumor; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Homeodomain Proteins; Humans; Poly A; Precursor T-Cell Lymphoblastic Leukemia-Lymphoma; Proto-Oncogene Proteins; RNA Interference; RNA, Long Noncoding; Sequence Analysis, RNA; T-Lymphocytes; Triazoles | 2018 |
Invasive mucormycosis without radiological alterations.
Topics: Adolescent; Amphotericin B; Antifungal Agents; Female; Fungi; Humans; Liposomes; Mucormycosis; Neutropenia; Precursor T-Cell Lymphoblastic Leukemia-Lymphoma; Recurrence; Remission Induction; Stem Cell Transplantation; Tomography, X-Ray Computed; Triazoles | 2013 |
An epigenetic mechanism of resistance to targeted therapy in T cell acute lymphoblastic leukemia.
Topics: Amyloid Precursor Protein Secretases; Animals; Azepines; Cell Cycle Proteins; Cell Line, Tumor; Chromatin; Chromatin Immunoprecipitation; Drug Resistance, Neoplasm; Enzyme Inhibitors; Enzyme-Linked Immunosorbent Assay; Epigenesis, Genetic; Flow Cytometry; Gene Expression Regulation, Neoplastic; Histones; Humans; Indoles; Mice; Nuclear Proteins; Precursor T-Cell Lymphoblastic Leukemia-Lymphoma; Real-Time Polymerase Chain Reaction; Receptor, Notch1; Signal Transduction; Transcription Factors; Triazoles | 2014 |
Epigenetic mechanisms underlie resistance to NOTCH inhibition in T-ALL.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Azepines; Drug Resistance, Neoplasm; Epigenesis, Genetic; Humans; Oligopeptides; Precursor T-Cell Lymphoblastic Leukemia-Lymphoma; Receptor, Notch1; Triazoles | 2014 |
Therapeutic targeting of c-Myc in T-cell acute lymphoblastic leukemia, T-ALL.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Azepines; Drug Screening Assays, Antitumor; Drug Synergism; Histone Deacetylase Inhibitors; Humans; Mice; Nylons; Precursor T-Cell Lymphoblastic Leukemia-Lymphoma; Proto-Oncogene Proteins c-myc; Pyrroles; Triazoles; Xenograft Model Antitumor Assays | 2014 |
Co-targeting of Akt and Myc inhibits viability of lymphoma cells from Lck-Dlx5 mice.
Topics: Animals; Apoptosis; Azepines; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Proliferation; Cell Survival; Everolimus; Homeodomain Proteins; Imidazoles; Lymphocyte Specific Protein Tyrosine Kinase p56(lck); Mice; Precursor T-Cell Lymphoblastic Leukemia-Lymphoma; Proto-Oncogene Proteins c-akt; Proto-Oncogene Proteins c-myc; Quinolines; Signal Transduction; Thiazoles; Transcription, Genetic; Triazoles; Vincristine | 2015 |
CK2 inhibitor CX-4945 destabilizes NOTCH1 and synergizes with JQ1 against human T-acute lymphoblastic leukemic cells.
Topics: Azepines; Casein Kinase II; Cell Line, Tumor; Drug Synergism; Female; Humans; Male; Naphthyridines; Neoplasm Proteins; Phenazines; Precursor T-Cell Lymphoblastic Leukemia-Lymphoma; Protein Stability; Receptor, Notch1; Triazoles | 2017 |
Targeting BET proteins improves the therapeutic efficacy of BCL-2 inhibition in T-cell acute lymphoblastic leukemia.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Azepines; Bcl-2-Like Protein 11; Bridged Bicyclo Compounds, Heterocyclic; Cell Cycle Proteins; Cell Line, Tumor; Drug Synergism; Female; Gene Expression Regulation, Neoplastic; Humans; Mice; Mice, Inbred NOD; Mice, SCID; Molecular Targeted Therapy; Neoplasm Proteins; Nuclear Proteins; Precursor T-Cell Lymphoblastic Leukemia-Lymphoma; Protein Domains; Proto-Oncogene Proteins c-bcl-2; Sulfonamides; Transcription Factors; Triazoles; Xenograft Model Antitumor Assays | 2017 |
CD26/DPPIV cell membrane expression and DPPIV activity in plasma of patients with acute leukemia.
Topics: Adolescent; Cell Membrane; Child; Dipeptidyl Peptidase 4; Dipeptidyl-Peptidase IV Inhibitors; Dose-Response Relationship, Drug; Flow Cytometry; Gene Expression Regulation, Neoplastic; Humans; Immunophenotyping; Kinetics; Lymphocyte Activation; Precursor T-Cell Lymphoblastic Leukemia-Lymphoma; Pyrazines; Reference Values; Sitagliptin Phosphate; Triazoles; Young Adult | 2009 |
Regulation of PTEN by CK2 and Notch1 in primary T-cell acute lymphoblastic leukemia: rationale for combined use of CK2- and gamma-secretase inhibitors.
Topics: Amyloid Precursor Protein Secretases; Blotting, Western; Casein Kinase II; Cell Proliferation; Cell Size; Child; Dichlororibofuranosylbenzimidazole; Drug Therapy, Combination; Enzyme Inhibitors; Gene Expression Regulation, Leukemic; Humans; Mutation; Precursor T-Cell Lymphoblastic Leukemia-Lymphoma; PTEN Phosphohydrolase; Receptor, Notch1; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Signal Transduction; Triazoles | 2010 |
Fatal invasive trichosporonosis due to Trichosporon loubieri in a patient with T-lymphoblastic lymphoma.
Topics: Antifungal Agents; DNA, Fungal; DNA, Ribosomal Spacer; Fatal Outcome; Female; Fungemia; Humans; Immunocompromised Host; Molecular Sequence Data; Mycoses; Precursor T-Cell Lymphoblastic Leukemia-Lymphoma; Pyrimidines; Sequence Analysis, DNA; Triazoles; Trichosporon; Voriconazole; Young Adult | 2011 |
Combination of a selective activator of the glucocorticoid receptor Compound A with a proteasome inhibitor as a novel strategy for chemotherapy of hematologic malignancies.
Topics: Apoptosis; Boronic Acids; Bortezomib; Cell Line, Tumor; Dexamethasone; Dimerization; Drug Synergism; Hematologic Neoplasms; Humans; K562 Cells; Lymphoma; NF-kappa B; Precursor T-Cell Lymphoblastic Leukemia-Lymphoma; Proteasome Inhibitors; Pyrazines; Receptors, Glucocorticoid; RNA Interference; RNA, Small Interfering; Transcription Factor AP-1; Transcriptional Activation; Triazoles; Tumor Cells, Cultured | 2013 |